4//SEC Filing
LaBrosse Nicole 4
Accession 0001415889-25-024295
CIK 0001159036other
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 5:09 PM ET
Size
15.1 KB
Accession
0001415889-25-024295
Insider Transaction Report
Form 4
LaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Option to Purchase Common Stock
2025-09-10−1,135→ 812 totalExercise: $12.49Exp: 2027-08-01→ Common Stock (1,135 underlying) - Exercise/Conversion
Common Stock
2025-09-10$12.07/sh+11,271$136,041→ 43,171 total - Exercise/Conversion
Common Stock
2025-09-10$12.49/sh+1,135$14,176→ 44,306 total - Sale
Common Stock
2025-09-10$75.93/sh−13,240$1,005,300→ 24,306 total - Sale
Common Stock
2025-09-10$75.29/sh−6,760$508,967→ 37,546 total - Exercise/Conversion
Option to Purchase Common Stock
2025-09-10−11,271→ 0 totalExercise: $12.07Exp: 2027-02-22→ Common Stock (11,271 underlying)
Footnotes (5)
- [F1]The option exercises and sales reported on this Form 4 were effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2025.
- [F2]Represents a weighted average sales price per share. These shares were sold at prices ranging from $74.56 to $75.55. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]Represents a weighted average sales price per share. These shares were sold at prices ranging from $75.56 to $76.30. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F4]This option was granted on February 22, 2017 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter.
- [F5]This option was granted on August 1, 2017 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter.
Documents
Issuer
HALOZYME THERAPEUTICS, INC.
CIK 0001159036
Entity typeother
Related Parties
1- filerCIK 0001910662
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 5:09 PM ET
- Size
- 15.1 KB